THE ROLE OF PROTEIN TURNOVER IN AGING
THE ROLE OF PROTEIN TURNOVER IN AGING
批准号:
6941598
负责人:
ALEXEY G. RYAZANOV
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-15 至 2007-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term goal is to elucidate the
role of protein synthesis and turnover in aging. We are particularly
interested in the role of protein turnover in the molecular mechanism(s)
responsible for the anti-aging effect of caloric restriction. We have
identified a novel protein kinase, elongation factor-2 (eEF-2) kinase, that
can modulate the rate of protein synthesis in animal cells (Ryazanov et. al.,
(1988) Nature 334: 170-173; Ryazanov et al., (1997) Proc. Natl. Acad. Sci. 94:
4884-4889). We found that a knockout of eEF-2 kinase in Caenorhabditis
elegans results in an increase in protein turnover, and extends life span.
Conversely, overexpression of eEF-2 kinase in transgenic nematodes shortens
life span. It has long been discussed that protein synthesis and turnover can
play a causative role in aging. Our results provide the first direct
experimental support of this hypothesis. From our preliminary experiments, we
suggest that inactivation of eEF-2 kinase and the resulting increase in
protein synthesis and degradation leads to a more efficient removal of
oxidatively damaged proteins, and thus extends life span. In addition, up-
regulation of protein synthesis through inhibition of eEF-2 kinase may
contribute to the anti-aging effect of caloric restriction.
In this grant application, we will use both C. elegans and mice as model
systems. We plan to elucidate the molecular mechanism of protein synthesis
inhibition during aging and to investigate the role of eEF-2 kinase and
protein turnover in the anti-aging effect of caloric restriction. We will
also analyze the rote of eEF-2 kinase in normal senescence and caloric
restriction in mammals using the eEF-2 kinase knockout mice we recently
obtained. The experiments described in this grant application are designed to
provide a foundation for the development of novel therapeutic reagents that
can mimic caloric restriction, circumventing some of the deleterious
consequences of aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy
-
批准号:8782369
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2014
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Investigation of synergism between mTOR and eEF2 kinase pathways
-
批准号:8727812
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Investigation of synergism between mTOR and eEF2 kinase pathways
-
批准号:8729435
-
项目类别:
-
资助金额:$18.78万
-
财政年份:2012
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Investigation of synergism between mTOR and eEF2 kinase pathways
-
批准号:8445866
-
项目类别:
-
资助金额:$23.72万
-
财政年份:2012
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Translational Control of Radiation-Induced Apoptosis
-
批准号:8204921
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2009
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Translational Control of Radiation-Induced Apoptosis
-
批准号:8018134
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2009
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Development of New Drugs that Protect Gastrointestinal Tract from Radiation
-
批准号:7890856
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2009
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Translational Control of Radiation-Induced Apoptosis
-
批准号:7764154
-
项目类别:
-
资助金额:$6.11万
-
财政年份:2009
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains
-
批准号:7285826
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Regulation of Metal Ion Homeostasis by Channel Kinases
-
批准号:7248888
-
项目类别:
-
资助金额:$185.3万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Regulation of Metal Ion Homeostasis by Channel Kinases
-
批准号:7843623
-
项目类别:
-
资助金额:$174.99万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Regulation of Metal Ion Homeostasis by Channel Kinases
-
批准号:8138424
-
项目类别:
-
资助金额:$172.15万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Regulation of Metal Ion Homeostasis by Channel Kinases
-
批准号:7690825
-
项目类别:
-
资助金额:$172.73万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Core A: Administrative Support
-
批准号:7285833
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Development of New Drugs that Protect Gastrointestinal Tract from Radiation
-
批准号:7472938
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
Regulation of Metal Ion Homeostasis by Channel Kinases
-
批准号:7409180
-
项目类别:
-
资助金额:$169.11万
-
财政年份:2007
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
THE ROLE OF PROTEIN TURNOVER IN AGING
-
批准号:6533940
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2001
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
THE ROLE OF PROTEIN TURNOVER IN AGING
-
批准号:6401188
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2001
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
THE ROLE OF PROTEIN TURNOVER IN AGING
-
批准号:6649758
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2001
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
THE ROLE OF PROTEIN TURNOVER IN AGING
-
批准号:6795940
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2001
-
负责人:ALEXEY G. RYAZANOV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: